A branded prescription from a questionnaire is still a prescription without a protocol. Branded settles what is in the pen. It does not settle whether it is the right medicine and dose for you. It does not settle what happens three months from now either.

Branded GLP-1 is no longer hard to find online. Several telehealth services now offer Wegovy or Zepbound after a short form. The medicine that arrives is the real, FDA-approved product. That is genuine progress.

This piece explains the difference between a prescription and a biomarker-tested, clinically guided protocol. It covers what a questionnaire can and cannot know, what a protocol adds and why that difference decides how well a GLP-1 works for you over the years ahead.

Key Takeaways
  • Branded medication solves one problem: you know exactly what you are taking. It does not tell anyone why your weight, insulin or lipids moved.
  • A questionnaire collects what you type. A protocol starts from what your blood shows: Fasting Insulin, HbA1c, ApoB, Lipoprotein (A), thyroid and more.
  • At GoodLife Health, a clinician reads nine biomarkers before any decision and every 90 days after. The protocol is adjusted to your own results.
  • One flat fee of $299 a month at every dose means nobody gains anything when your dose goes up.
  • The goal is long-term health measured over years, with weight as one part of it.

What does a questionnaire collect?

A questionnaire asks for your height, your weight, your current conditions, the medicines you take and a set of safety questions. That information is enough to screen out people for whom a GLP-1 would plainly be unsafe. It is also enough, in many cases, for a prescriber to write a starting dose.

What it cannot collect is anything you do not already know about yourself. You may never have seen your Fasting Insulin or your ApoB. You may not have had a thyroid test in years. The questionnaire does not know whether weight gain over a decade came with a rising HbA1c, a thyroid running slow or a lipid pattern that shifted after menopause. It records the weight. It cannot read the reasons behind it.

What does a protocol need?

A questionnaire prescription and a clinically guided protocol

How GoodLife Health works, November 2026

QuestionQuestionnaire prescriptionClinically guided protocol
What is known before a decisionWhat you typedNine biomarkers drawn at Quest, read with your history
Insulin and blood sugarNot measuredFasting Insulin and HbA1c on every panel
Heart riskNot measuredApoB, Lipoprotein (A), lipids and Hs-CRP on every panel
ThyroidSelf-reportedTSH With Reflex To Free T4 on every panel
Follow-upWhen you next request a refillA panel and a protocol review every 90 days
Dose decisionsOften follow a scheduleMade with you, from your response and your markers

The nine biomarkers on every GoodLife Health panel are Hs-CRP, the Comprehensive Metabolic Panel, TSH With Reflex To Free T4, Fasting Insulin, Lipoprotein (A), HbA1c, the standard Lipid Panel, ApoB and a CBC with differential and platelets. They are drawn at a Quest patient service center in the morning after an 8- to 12-hour fast with water only. Results usually return in 9 to 13 days.

What is a clinically guided protocol?

A protocol is the plan around the medicine, written and then rewritten as your body answers. At GoodLife Health it has four parts.

  • Clinical care. A clinician reads your markers together before any decision and decides with you. The answer might be a GLP-1, a different dose, something else first or nothing at all.
  • A protocol. It is built on your own numbers rather than on a dosing schedule. No dose goes up only because a higher one exists.
  • Guidance. Your clinician asks the same practical questions at every review, not only when something goes wrong.
  • A longevity focus. ApoB, Lipoprotein (A), HbA1c and inflammation are measured every 90 days, because the goal is your long-term health and not only the number on the scale.

These are the questions Kristin Makinajyan, our medical director, asks a member already on a GLP-1:

Kristin Makinajyan, DNP, FNP-BC

"Is the current dose still working? Is appetite controlled without being completely suppressed? Are we maintaining strength and protein intake? Are there side effects that are starting to become more important over time?"

Improvement sometimes means taking something away rather than adding more. A protocol makes room for that answer. A refill request rarely does.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

What does each marker tell a GLP-1 protocol?

Each marker on the panel answers a question a questionnaire cannot.

  • Fasting Insulin and HbA1c. Together they show how your body handles blood sugar. HbA1c reflects the average of the last few months. Fasting Insulin can rise long before HbA1c does, which is why the two are read side by side.
  • ApoB, Lipoprotein (A) and the Lipid Panel. These describe heart risk. ApoB counts the particles that carry cholesterol. Lipoprotein (A) is largely inherited and is worth knowing at least once. The Lipid Panel adds LDL, HDL and triglycerides.
  • Hs-CRP. A measure of inflammation that adds context to heart risk.
  • TSH With Reflex To Free T4. Thyroid function. TSH is run on every draw. Free T4 is added by the lab only when the TSH result calls for it.
  • The Comprehensive Metabolic Panel. Kidney and liver function, glucose and electrolytes, which matter for any medication plan.
  • The CBC. Red and white cells and platelets, a basic safety check.

Read once, these are a snapshot. Read every 90 days against your own last result, they show whether the protocol is moving you in the right direction. If you want to go deeper on one of them, ApoB on a GLP-1 explains what to do when it rises.

Why does the dose question matter most?

Most GLP-1 medicines come with a titration schedule, a sequence of rising doses. A schedule is a reasonable default. It is not a diagnosis. Some people do well at a lower dose and gain nothing from going higher except more side effects and a larger bill. Others stall for reasons a higher dose will not fix.

"I don't automatically increase a GLP-1 every month because the dosing schedule says that another dose exists."

Kristin Makinajyan, DNP, FNP-BC

The structure of the fee matters here. GoodLife Health charges $299 a month at every dose and takes nothing on medication, which your pharmacy bills at its own price. Nobody at GoodLife Health earns more when your dose rises. We explain why that structure matters in the GLP-1 dose escalation trap.

What happens when weight stalls?

Plateaus are common. The reflex is to raise the dose. A protocol asks why first. The answer often sits in the markers. A Fasting Insulin that has stopped improving, a thyroid result that has drifted or a medication that works against the GLP-1 can each explain a stall that more medicine would not fix. Sometimes the answer is protein, sleep or strength work. The decision is made with you, from the evidence.

A plateau is information. Read against your last panel, it often points to the next step more clearly than a schedule can. Sometimes that step is a change in dose. Often it is something else entirely.

What happens after goal weight?

A prescription has no plan for the day you reach your goal. A protocol does. Maintenance is a chapter of the care. The markers keep being measured every 90 days. Decisions about dose, tapering or continuing are made with your clinician against your own results. Our guide to what a GLP-1 program should include covers the long run in more detail.

What should you ask your current prescriber?

If you already have a branded prescription, these questions will tell you quickly whether there is a protocol behind it.

  1. Which labs did you read before prescribing? Ask for the names and the dates.
  2. When will my labs be repeated? A protocol has a schedule. A prescription usually has a refill date.
  3. How will you decide my next dose? Listen for your response and your markers, not only the titration chart.
  4. Who do I message about side effects? Ask whether it is the same clinician each time.
  5. What is the plan after I reach my goal? A protocol has an answer before you get there.

If the answers are clear, you may already have what you need. If they are not, that is the gap a membership fills.

What does a year of protocol look like?

  1. The baseline. Nine biomarkers are drawn at Quest within days of joining. Your clinician reads them with you and writes the protocol.
  2. The start. If treatment is indicated, it begins in the second month, prescribed to the pharmacy you choose.
  3. The first review. Ninety days after your baseline, the panel is drawn again. Your clinician compares it with the first and adjusts the protocol.
  4. The second review. At about six months, a third panel shows whether the direction has held. Dose, protein, strength and side effects are reviewed together.
  5. The third review. At about nine months, the fourth panel completes the year. You now have four readings of the same nine markers, read by your clinician.

By the end of the year, the protocol rests on a record of how your own body answered. A questionnaire cannot produce that record, however good the medicine it leads to.

Is the questionnaire route ever enough?

Sometimes. If your own doctor orders and reads your labs on a schedule, a branded prescription from a questionnaire can sit inside a protocol you already have. The prescription supplies the medicine. Your doctor supplies the reading and the follow-up. What matters is that someone does that work. When nobody does, the medicine is working without a guide.

What does it cost?

The membership is $299 a month at every dose. Year one is $3,588. Your first two months are covered by a $598 hold, charged only once a clinician accepts you into care. If a clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are non-refundable. From the third month, you can cancel at any time. Additional labs beyond the quarterly panel are billed separately by the lab. Medication is prescribed to the pharmacy you choose, at that pharmacy's own price. Our medical weight loss membership page sets out everything the fee includes.

Who is this not for?

If speed matters most, a questionnaire service will get you a prescription faster. That may be the right call for you. The membership is built for people who want the reasoning behind every dose. It is not designed for anyone seeking compounded GLP-1 or a guaranteed result. It sits alongside your health insurance rather than replacing it. Membership is open to adults living in the United States.

Frequently Asked Questions

Is a branded prescription from a questionnaire safe?

A branded medicine is FDA-approved. A questionnaire can screen out people for whom a GLP-1 would plainly be unsafe. What it cannot do is read your markers or follow your response over time. That is the work of a protocol.

What does a biomarker-tested protocol measure?

Nine biomarkers at every panel: Hs-CRP, the Comprehensive Metabolic Panel, TSH With Reflex To Free T4, Fasting Insulin, Lipoprotein (A), HbA1c, the standard Lipid Panel, ApoB and a CBC. They are drawn at Quest before any decision and every 90 days after.

Will my clinician raise my dose on a schedule?

No dose goes up only because a higher one exists. Your clinician decides with you from your response, your side effects and your markers.

I already have a branded prescription. Can I bring it?

Yes. Tell us what you take and the dose. Your clinician reads your baseline panel against your current medication and tells you plainly what continues, what changes and why.

Does the membership fee include the medication?

No. Medication is billed by your pharmacy at its own price. GoodLife Health takes nothing on it. The fee is $299 a month whatever the medication or dose.

Related Reading

References

  1. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss, current as of October 1, 2026. fda.gov
  2. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021. pubmed
  3. Quest Diagnostics. Find a patient service center. questdiagnostics.com